ADVERTISEMENT
ADVERTISEMENT
white squiggles on black background
Opinion: Manuscripts and Art Support Archaeological Evidence that Syphilis Was in Europe Long Before Explorers Could Have Brought It Home from the Americas
Marylynn Salmon, The Conversation | Jul 13, 2022 | 5 min read
Multiple lines of evidence contradict the idea that the disease came to Europe via trans-Atlantic exchange.
illustration of a coronavirus and antibodies
When the Immune Response Makes COVID-19 Worse
Alejandra Manjarrez, PhD | Sep 27, 2021 | 8 min read
If the immune system makes mistakes—reacting late or getting the target wrong—it can amplify the damage wrought by SARS-CoV-2.
Watercolor coronaviruses in green, red, blue, and purple are layered above an abstract background of watercolor swashes
Plenty of Evidence for Recombination in SARS-CoV-2
Abby Olena, PhD | Sep 2, 2021 | 7 min read
Different variants of the virus behind the COVID-19 pandemic are swapping chunks of genetic material, but it’s not yet clear what implications that may have for public health.
Illustration showing the bodily systems affected by Long COVID
Infographic: Bodily Systems Affected by Long COVID
Sruthi S. Balakrishnan | Sep 1, 2021 | 1 min read
Symptoms documented in cases of long COVID are wide ranging and variable.
Illustration of a person sick next to a calendar indicating they've had covid for a long time
Mechanisms of Long COVID Remain Unknown but Data Are Rolling In
Sruthi S. Balakrishnan | Sep 1, 2021 | 10+ min read
A year and a half into the pandemic, the long-term effects of SARS-CoV-2 infection are garnering more research attention as millions of long COVID patients emerge.
A collection of headshots
Contributors
The Scientist | Aug 1, 2021 | 4 min read
Meet some of the people featured in the August 2021 issue of The Scientist.
The Researchers Who Pivoted to COVID-19: One Year On
Shawna Williams | Jul 1, 2021 | 7 min read
The Scientist checks in on scientists who switched gears to combat the pandemic.
An illustration of several human heads wearing masks
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Jef Akst | Jun 18, 2021 | 4 min read
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
A black line drawing of a mother putting a face mask on a child with a white background
SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C
Alejandra Manjarrez, PhD | Jun 3, 2021 | 4 min read
Researchers find traces of SARS-CoV-2 in the stool and blood of kids with the post–COVID-19 inflammatory disorder, and signs of increased intestinal permeability.
Opinion: Comparing Coronaviruses
Nicola Petrosillo | Jun 1, 2021 | 4 min read
In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.
A stylized, computer-generated 3D render of a virus cell that looks similar to SARS-CoV-2
Two New Coronaviruses Make the Leap into Humans
Amanda Heidt | May 20, 2021 | 3 min read
Two viruses from dogs and pigs were isolated from human patients, but neither was proven to cause severe disease or to transmit to other people.
Amanda Tokash-Peters Links the Microbiome to Ecology
Shawna Williams | May 1, 2021 | 3 min read
The Centenary University professor studies the far-reaching effects of changes in the gut bacteria of mosquitos and other species.
Dicks Sporting Goods Park stadium from a distance with mountains in the background
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
Shawna Williams | Apr 9, 2021 | 3 min read
Vaccinations with the Johnson & Johnson jab paused at several sites earlier this week after an unusual number of people experienced adverse reactions, but the CDC says there’s no cause for concern.
mis-c multisystem inflammatory syndrome in children covid-19 coronavirus pandemic sars-cov-2 antibody cardiac inflammation icu intensive care kids infection vomiting abdominal pain diarrhea fever
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Kerry Grens | Apr 7, 2021 | 2 min read
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine
Lisa Winter | Apr 6, 2021 | 2 min read
Stanford University researchers determined the code from spare drops in discarded vials of the COVID-19 vaccine and published it on GitHub.
diabetes, type 1, type 2, COVID-19, SARS-CoV-2, coronavirus, pandemic, registry
A Global Registry Aims to See if COVID-19 Causes Diabetes
Asher Jones | Mar 19, 2021 | 2 min read
Researchers have collected hundreds of COVID-19–related diabetes case reports since August of last year, in hopes of teasing apart the complex links between the two diseases.
AstraZeneca, University of Oxford, vaccine, COVID-19, SARS-CoV-2, pandemic, coronavirus, vaccination, safety, Europe
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021 | 2 min read
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021 | 6 min read
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
Interim Report on Origin of SARS-CoV-2 Scrapped by WHO
Lisa Winter | Mar 5, 2021 | 2 min read
Instead, the full report will be available in mid-March.
COVID-19, SARS-CoV-2, pandemic, research, reverse genetics, toolkit, antibodies, RNA
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021 | 6 min read
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
ADVERTISEMENT